Cohance to invest Rs 110 crore in new global facilities
Manufacturing
Aug 14,2025
Cohance Lifesciences is set to invest Rs 110 crore in expanding its facilities in Hyderabad, India, and New Jersey, USA.
The investment includes $10 million (approx. ₹87 crore) for enhancing its cGMP bioconjugation capabilities at its US subsidiary, NJ Bio.
Additionally, Rs 23 crore will be invested in a new cGMP oligonucleotide building block manufacturing facility in Hyderabad.
This strategic expansion will allow Cohance to scale up high-value chemistries and strengthen its position as a key partner for global innovators in the rapidly growing field of next-generation therapeutics
Company :
|
Cohance Lifesciences